Treatment Registry
TR-0613 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Potere Health MD · Injection, vial · every compounded tirzepatide record

Recorded initial charges

First month

$299.99

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · 3rd fill and beyond · recorded initial monthly payment$299.99

Added from the figures recorded below.

Price

TermPer monthCharged today
3rd fill and beyond

“60 mg of compounded Tirzepatide costs $299.99 on your 3rd fill and beyond.”

Per month$299.99Charged today$299.99
Price sources
Visit Potere Health MD

We earn nothing from this link. It opens Potere Health MD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyKaduceus Pharmacy
StatesUtah
PrescriberLive visit

Not yet checked: cancellation, membership and consult fee.

Recorded from poterehealthmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0613
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Potere Health MD

All Potere Health MD programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Potere Health MD — compounded tirzepatide (TR-0613). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0613

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.